Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment

被引：0
|
作者：
Marshall, Fray F.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 184卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1303 / 1303
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma
    Li Xue-song
    Wu Xiang
    Zhao Peng-ju
    Huang Li-hua
    Song Yi
    Gong Kan
    Shen Cheng
    Yu Wei
    Song Gang
    Zhao Zheng
    Zhang Zheng
    Zhang Qian
    Wang Gang
    He Zhi-song
    Zhou Li-qun
    Jin Jie
    CHINESE MEDICAL JOURNAL, 2011, 124 (18) : 2920 - 2924
  • [42] Editorial Comment to Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
    Kondo, Tsunenori
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (04) : 351 - 352
  • [43] Editorial Comment to Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan
    Izumi, Kouji
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (02) : 210 - 211
  • [44] Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 809 - 809
  • [45] The safety and efficacy of pazopanib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Boleti, Ekaterini
    Sarwar, Naveed
    Jones, Robert R.
    Chowdhury, Simon
    Crabb, Simon J.
    Shamash, Jonathan
    Peters, John
    Oades, Grenville
    O'Brien, Tim S.
    Berney, Dan
    Rockall, Andrea
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [46] Safety and tolerability of pazopanib in the treatment of renal cell carcinoma
    Zivi, Andrea
    Cerbone, Linda
    Recine, Federica
    Sternberg, Cora N.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) : 851 - 859
  • [47] Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)
    Osanto, S.
    Hutson, T. E.
    Calvo, E.
    Escudier, B. J.
    Oudard, S.
    Porta, C.
    Bracarda, S.
    Grunwald, V.
    Ravaud, A.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Yuki Nemoto
    Hiroki Ishihara
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Kazunari Tanabe
    Tsunenori Kondo
    Toshio Takagi
    International Urology and Nephrology, 2022, 54 : 47 - 54
  • [49] INITIAL EVALUATION OF THE CLINICAL EFFICACY AND SAFETY OF AXITINIB IN METASTATIC RENAL CELL CARCINOMA PATIENTS
    Miura, N.
    Noda, T.
    Nishimura, K.
    Shirato, A.
    Yanagihara, Y.
    Miyauchi, Y.
    Kikugawa, T.
    Tanji, N.
    Yokoyama, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 90 - 90
  • [50] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (01) : 47 - 54
12345